Please login to the form below

Not currently logged in

Pfizer, BioNTech's COVID-19 vaccine is 95% effective, final analysis shows

Pfizer BiontechVaccine is over 94% effective in adults over 65 years of age

NHS asked to ‘ready’ itself to provide Pfizer’s COVID-19 vaccine

nhsHealth Secretary Matt Hancock expects widespread roll-out early next year

Gilead’s remdesivir not included in WHO’s COVID-19 drug scheme

GileadRemdesivir not included as a priority drug, Reuters reports

NHS gearing up for possible pre-Christmas COVID-19 vaccinations

NHS England logoNHS chief exec said the NHS is getting ready to administer vaccines

Best practice in UK diabetes celebrated at virtual QiC Diabetes Awards 2020

QiC Diabetes 2020Award ceremony was held virtually this year due to COVID-19 pandemic

Nearly 16,000 coronavirus cases left out of UK's daily figures between 25 September and 2 October

LondonPHE chief exec says ‘technical issue’ caused unreported coronavirus cases

Widespread COVID-19 vaccinations not expected until mid-2021, says WHO

WHOPotential candidates must prove robust efficacy and safety first

EU to contribute €400m to WHO’s COVID-19 vaccine facility

EU flagContribution will go towards ensuring equitable access to COVID-19 vaccines

EU flag bodyWho's calling the shots in European healthcare?

Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...